How to buy Wegovy tablets online (UK only)

Wegovy tablets have now been approved by the MHRA in the UK. You are now eligible to place orders through Chemist Cick.

All orders are subject to clinical suitability and prescription approval.

Wegovy Tablet Prices

Name & Dosage	x30 Tablets
Wegovy 1.5mg Tablets	£88.99
Wegovy 4mg Tablets	£98.99
Wegovy 9mg Tablets	£124.99
Wegovy 25mg Tablets	£178.99

Wegovy tablets: quick facts

Medication Class	GLP-1 receptor agonist
Active ingredient	Semaglutide
How Wegovy tablets work	Reduces appetite Increases feeling of fullness Slows the rate at which food leaves the stomach
How to take Wegovy tablets	Take one tablet daily in the morning on an empty stomach. Wait 30 minutes before eating, drinking, or taking any other medication. Do not split, chew or crush Wegovy tablets.
Effective within	1-2 weeks: Appetite reduction 4-8 weeks: Noticeable weight loss 3-6 months onwards: Peak clinical effect
Average weight loss	13.6%-16.6%, according to clinical trials
UK approved?	Yes
Are they the same as Wegovy injections?	They contain the same active ingredient, semaglutide, but are taken daily by mouth instead of once weekly by injection.
Prescription required?	Yes. A prescription will only be issued after a clinical assessment.

About Wegovy Tablets

What are Wegovy tablets? How they work Results Safety Tablets vs Injections Switching from tablets to injections Prices

What are Wegovy tablets?

Wegovy tablets are an oral form of semaglutide designed to support weight loss. They contain the same active ingredient as Wegovy injections, but are taken by mouth instead of injected.

They are taken once daily and work by reducing appetite, increasing feelings of fullness and helping you eat fewer calories over time.

This makes them a potential needle-free alternative for people who want the benefits of semaglutide weight loss treatment without using injections.

How do Wegovy tablets work?

Wegovy tablets contain semaglutide, a GLP-1 receptor agonist.

They work by:

Reducing appetite and increasing feelings of fullness
Slowing stomach emptying, helping you stay satisfied for longer
Lowering cravings and caloric intake
Improving blood-sugar control and insulin sensitivity

An oral (tablet) form delivers semaglutide through the digestive system using absorption-enhancing technology so that enough medication enters the bloodstream to produce the same appetite-regulating effects as weight loss injections.

Wegovy tablets results

Key findings from late-stage studies (e.g., OASIS trials):

In the OASIS 4 trial, Wegovy tablets produced average weight loss of 13.6% using the treatment-policy estimate, and 16.6% in people who stayed on treatment, over 64 weeks
A third of participants lost 20% or more of their starting weight, within the same trial
A substantial proportion of patients achieved between 10-15% weight loss, levels associated with meaningful health benefits.
Appetite reduction and improved portion control were observed early, with progressive weight loss over time.

Source: Wharton S, et al. N Engl J Med 2025;393:1077–1087

Further reading: Wegovy tablets results

Are Wegovy tablets safe?

Wegovy tablets contain oral semaglutide, the same active ingredient as Wegovy injections. Clinical trials suggest they have a safety profile broadly similar to injectable Wegovy, with the most common side effects being nausea, vomiting, constipation and diarrhoea.

Most digestive side effects were mild to moderate and improved over time, but Wegovy tablets are not suitable for everyone and should only be used after a clinical assessment.

Wegovy tablets vs injections

Feature	Wegovy Injections	Wegovy Tablets (Oral Semaglutide)
Form	Once-weekly injection	Daily tablet
Availability	Approved and available in the UK	Approved in the UK. Available shortly.
Effectiveness	Around 15% average weight loss with standard 2.4mg dosing; higher-dose Wegovy injections may produce more.	Around 17% average weight loss in trials
Convenience	Weekly dosing, requires injection	No needles; taken by mouth
Onset & consistency	Highly reliable absorption	Absorption can be more variable
Side-effect profile	Similar GLP-1 effects (nausea, GI symptoms)	Similar GLP-1 effects

Further reading: Wegovy tablets vs injections

Can you switch from Wegovy injections to tablets?

Yes, you can switch from Wegovy injections to Wegovy tablets if your prescriber confirms it is suitable. Current prescribing guidance supports switching from Wegovy 2.4mg once-weekly injection to Wegovy 25mg once-daily tablets, starting the tablet 7 days after the last injection. Lower injection doses do not have the same guidance and will be at the discretion of your prescriber.

Current Wegovy injection stage	Wegovy injection (weekly)	Wegovy tablet (daily)
Starting dose	0.25mg	1.5mg
Step 2	0.5mg	1.5mg
Step 3	1mg	4mg
Step 4	1.7mg	9mg
Maintenance dose	2.4mg	25mg
Higher-dose injection	7.2mg	25mg

Further reading: Switching from Wegovy injections to tablets

The lower-dose switching suggestions in this table are approximate and based on clinical judgement, not official dose equivalence.

How much do Wegovy tablets cost in the UK?

Wegovy pills start from £88.99 per month for the lowest dose. As your dose increases, so will the price. The highest dose of 25mg is priced at £178.99.

How to take Wegovy tablets

Wegovy tablets should be taken once a day, first thing in the morning, on an empty stomach. Take the tablet with a small amount of plain water only, then wait at least 30 minutes before eating, drinking, or taking any other oral medicines.

The tablet must be swallowed whole. Do not split, crush, chew or dissolve it, as this may affect how the medicine is absorbed.

Step-by-step instructions

Step	What to do
1	Take Wegovy tablets once daily in the morning.
2	Take the tablet on an empty stomach.
3	Swallow the tablet whole with plain water only.
4	Do not take it with tea, coffee, juice, milk, fizzy drinks or any other liquid.
5	Wait at least 30 minutes before eating, drinking or taking other oral medicines.
6	Take it the same way every day to help the medicine absorb properly.

Further reading: How to take Wegovy tablets

Wegovy tablets dosage

Treatment Phase	Time Period	Dose	Schedule
Starter Dose	Month 1	1.5mg	Once daily
Titration 1	Month 2	4mg	Once daily
Titration 2	Month 3	9mg	Once daily
Maintenance	Month 4 onwards	25mg	Once daily

You begin on a low dose to minimise stomach upset.
The dose is gradually increased over the first three months. Your prescriber may wish to keep you at one dose for longer than a month to allow your body more time to adjust.
From month four, you stay on a maintenance dose designed to give the best balance of appetite control and weight loss.
Tablets would typically be taken once daily, often on an empty stomach with water, to ensure proper absorption.

Source: Wegovy® Pill Guide and Dosing Information | Wegovy® (semaglutide)

Further reading: Wegovy tablets dosage

Side effects of Wegovy tablets

The most common side effects are digestive symptoms, particularly when starting treatment or increasing the dose. Very common side effects affect at least 1 in 10 people. Common side effects affect between 1 in 100 and 1 in 10 people.

Frequency	Side effect	How to manage symptoms
Very common	Nausea	Eat smaller meals, avoid greasy or rich foods, eat slowly, and stop eating when full. Symptoms often improve as your body adjusts.
Very common	Diarrhoea	Drink plenty of fluids to prevent dehydration. Avoid very fatty foods, alcohol and large meals. Seek advice if diarrhoea is severe or persistent.
Very common	Vomiting	Take small sips of water regularly. Avoid large meals and seek medical advice if vomiting continues or you cannot keep fluids down.
Very common	Constipation	Increase fluids, fibre and gentle movement. Consider speaking to a pharmacist about a suitable constipation remedy if needed.
Very common	Stomach pain or abdominal discomfort	Eat smaller portions and avoid heavy, spicy or high-fat meals. Seek urgent advice if pain is severe, persistent or spreads to the back.
Very common	Headache	Stay hydrated and eat regularly where possible. Speak to a pharmacist about suitable pain relief if needed.
Very common	Fatigue	Rest where needed, keep hydrated and avoid skipping meals completely. Symptoms may improve after the dose settles.
Common	Indigestion or dyspepsia	Eat smaller meals, avoid lying down soon after eating, and reduce spicy, acidic or fatty foods.
Common	Acid reflux or heartburn	Avoid late meals, large portions, alcohol and trigger foods. Raising the head of the bed may help night-time reflux.
Common	Bloating or abdominal distension	Eat slowly, avoid fizzy drinks, and reduce large or heavy meals. Gentle walking may help.
Common	Burping	Avoid carbonated drinks, chewing gum and eating too quickly. Smaller meals may reduce symptoms.
Common	Wind or flatulence	Reduce fizzy drinks and very large meals. Some people benefit from identifying and reducing trigger foods.
Common	Dizziness	Keep hydrated and avoid standing up too quickly. Seek advice if dizziness is persistent, severe or linked to fainting.
Common	Low blood sugar	Mainly relevant for people with type 2 diabetes using insulin or sulfonylureas. Monitor blood glucose and speak to your prescriber, as diabetes medicine may need adjusting.
Common	Gastroenteritis	Keep hydrated and rest. Seek medical advice if symptoms are severe, persistent, or there are signs of dehydration.
Common	Cold-like symptoms	Rest, fluids and simple pharmacy remedies may help. Seek advice if symptoms worsen or do not settle.
Common	Hair loss	This can occur during significant weight loss. Ensure adequate protein and micronutrient intake and seek advice if hair loss is severe or persistent.
Common	Gallstones	Seek medical advice if you develop upper right abdominal pain, fever, nausea, vomiting or yellowing of the skin or eyes.
Common	Increased heart rate	Seek medical advice if you notice a persistent racing heartbeat, palpitations, chest pain or shortness of breath.

When to seek urgent medical advice

Seek urgent medical advice if you develop severe or persistent stomach pain, repeated vomiting, signs of dehydration, yellowing of the skin or eyes, swelling of the face or throat, difficulty breathing, a neck lump, trouble swallowing, or significant mood changes.

Further reading: Wegovy tablets side effects

Wegovy tablet warnings

Wegovy tablets are not suitable for:

Individuals with a personal or family history of medullary thyroid carcinoma or MEN2
An allergy to semaglutide

Caution should be taken in people with:

Severe gastrointestinal disease
Type 2 diabetes
A history of diabetic retinopathy
A history of mental health concerns
An upcoming surgery where sedation is going to be used

Wegovy tablet interactions

Potential interactions are expected to mirror injectable semaglutide:

Diabetes medications (e.g., insulin, sulfonylureas) may increase the risk of low blood sugar.
Medications requiring rapid absorption may be affected because GLP-1 medicines slow gastric emptying.

Wegovy tablets when pregnant or breastfeeding

Oral Wegovy tablets are not recommended in pregnancy. Weight-loss medicines should be stopped if you are pregnant or planning pregnancy.
Oral Wegovy tablets are not recommended while breastfeeding. There is insufficient safety data regarding exposure to infants.

Frequently Asked Questions

Yes, Wegovy tablets are now available in the UK. They were approved by the MHRA on 11 June 2026 for weight management and are available privately with a prescription after a clinical assessment.

Yes. To order Wegovy tablets online, complete a consultation. Your order will be shipped within 24 hours, subject to clinical checks by a pharmacist.

Yes, they were approved by the MHRA on 11th June 2026.

Wegovy tablets have already been approved by the MHRA and are now available to order from UK pharmacies.

Wegovy tablets cost between £88.99 and £178.99 per month in the UK depending on the dose prescribed

Yes. Wegovy tablets are a form of oral semaglutide.

Semaglutide is the active ingredient in Wegovy, and the tablet version is designed to be taken by mouth rather than injected. It works by mimicking the GLP-1 hormone, helping reduce appetite, increase fullness and support weight loss.

No. Wegovy tablets and Rybelsus both contain oral semaglutide, but they are not the same treatment.

Rybelsus is licensed for type 2 diabetes, not weight loss, and is available in lower doses.

Wegovy tablets are higher-dose oral semaglutide tablets developed specifically for weight management in countries where they are approved.

Wegovy tablets contain oral semaglutide, while orforglipron is a different oral GLP-1 tablet being developed by Eli Lilly.

Both are tablets designed to support weight loss, but they contain different active ingredients.

Wegovy tablets appear to offer weight loss results broadly comparable with standard Wegovy 2.4mg injections, although they have not been directly compared in a head-to-head UK trial.

In the OASIS 4 trial, Wegovy tablets produced average weight loss of 16.6% in people who stayed on treatment. However, higher-dose Wegovy injections may produce greater average weight loss in some patients.

In the OASIS 4 trial, people taking Wegovy tablets lost an average of 16.6% of their body weight when they stayed on treatment.

Around one in three people lost 20% or more of their body weight. Individual results can vary depending on dose, diet, activity levels, side effects, treatment adherence and starting weight.

You may be eligible for Wegovy tablets if you have a BMI of 30 or above, or a BMI of 27 or above with a weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol.

A prescriber will assess your medical history and suitability before treatment is approved.

Oral Wegovy can be prescribed to adults who are overweight or living with obesity and meet the clinical eligibility criteria for weight-loss treatment. It should be used alongside a healthy diet and regular physical activity, and suitability must be confirmed by a qualified prescriber.

Yes, Wegovy tablets are classified as prescription only medications.

They should only be supplied after a clinical consultation to check whether treatment is suitable and safe. You should not buy Wegovy tablets from unregulated websites, social media sellers or marketplaces.

You will be required to complete a consultation. Your answers are then reviewed by a pharmacist, and a supply will be made it it is clinically safe to do so.

UK registered online pharmacy
Pharmacist-led weight loss service
Regulated prescription process
Clinical suitability checks
Ongoing weight loss support
Discreet delivery
Verified reviews
No unlicensed or counterfeit medicines

Authored by

Abbas Kanani

Superintendent Pharmacist

Written by Chemist Click

First created 7th May 2026

Last reviewed 3rd July 2026

Wegovy Tablets UK Oral Semaglutide Weight Loss Pills